Search for: "Astrazeneca"
Results 241 - 260
of 1,244
Sorted by Relevance
|
Sort by Date
1 Nov 2015, 10:08 pm
Perhaps this explains why AstraZeneca made this express point in its complaint: “[AstraZeneca] is not aware of any third-party trademark registrations covering the mark purple applied to capsules or pills for the treatment of GI diseases. [read post]
1 Mar 2023, 1:00 am
The application was rejected by the Swedish Intellectual Property Office, and the appeal by AstraZeneca dismissed by the Patent and Market Court.The Patent and Market Court of Appeal again dismissed the appeal. [read post]
13 Jul 2010, 2:31 am
321/05 AstraZeneca AB v Commission which has been conveniently summarised by Linklaters and Gibson Dunn. [read post]
14 Dec 2022, 12:00 am
In this article, we address these questions by drawing on our first-hand experience of shaping and driving the roll-out of AI governance within AstraZeneca, a biopharmaceutical company. [read post]
5 Aug 2009, 8:52 am
AstraZeneca knows that its early successes in defeating Seroquel lawsuits have given it momentum. [read post]
21 May 2009, 4:11 am
” Tony Jewell, the AstraZeneca spokesman, said that Seroquel was approved in 1997. [read post]
9 Aug 2007, 9:31 am
AstraZeneca Study Information Provided To Regulatory Agencies In May 2007 Currently The Subject of Their Ongoing Safety Reviews (Posted by Tom Lamb at DrugInjuryWatch.com) On August 9, 2007 the FDA and Health Canada issued email alerts about possible serious cardiac events in patients using the prescription heartburn drugs Nexium (esomeprazole) and Prilosec (omeprazole), made by AstraZeneca (AZN). [read post]
7 Jan 2008, 8:48 pm
Astrazeneca Pharmaceuticals LP et al. v. [read post]
20 Mar 2012, 2:29 pm
ABSTRACT: In the landmark 2005 Article 102 TFEU case regarding Losec, AstraZeneca was fined EUR 60 million for conduct that would not... [read post]
5 Sep 2012, 9:45 am
ABSTRACT: If the Court of Justice follows the Advocate General's advice and upholds the General Court's judgment in AstraZeneca, this... [read post]
2 Apr 2009, 3:56 am
AstraZeneca LP Addressing the oft-raised (recently) issue of whether pharmaceutical sales representative employees are subject to the Outside Sales exemption, the District Court answered the question in the affirmative and granted Defendant’s Motion for Summary Judgment on the issue. [read post]
25 Apr 2007, 9:09 pm
Noonan -- The end of the consolidated omeprazole litigation may have been reached this week, when the Federal Circuit ruled on AstraZeneca's appeal over the validity of U.S. [read post]
9 Sep 2020, 1:26 pm
AstraZeneca has put on hold studies of its vaccine candidate in ... [read post]
16 Jul 2011, 11:00 am
. “Today, there are only two Big Pharma companies, GlaxoSmithKline and AstraZeneca, with active antibiotic R&D programs . . . . [read post]
25 Apr 2023, 9:08 am
#LegalTweetoftheDay: Pharmacist ran $6.5M scheme against AstraZeneca before allegedly fleeing Canada, ruling finds #law #legal #lawtwitter via @CTVNews https://bit.ly/4468s5Z - Garry J. [read post]
20 Mar 2012, 2:29 pm
ABSTRACT: In the landmark 2005 Article 102 TFEU case regarding Losec, AstraZeneca was fined EUR 60 million for conduct that would not... [read post]
20 Nov 2009, 6:29 am
If so, I foresee a lot of money being spent by both sides to retain local counsel… Nov. 19 (Bloomberg) -- AstraZeneca Plc may face as many 6,000 trials of lawsuits claiming its antipsychotic drug Seroquel causes diabetes after a... [read post]
14 Mar 2007, 8:45 am
Continuing with the recent trend of incorporating the use of nanotechnology into medical devices, Astra Tech (a subsidiary of AstraZeneca) recently issued a press release regarding its OsseoSpeed™ implant material. [read post]
17 Jan 2008, 6:00 pm
Esomeprazole is a proton pump inhibitor (brand names Nexium ®; Lucen ®; Esopral ® and Axagon ® in Italy) developed and marketed by AstraZeneca which is used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and Zollinger-Ellison syndrome. [read post]
15 Apr 2016, 9:46 am
The fellowship at MedImmune, the global biologics research and development arm of AstraZeneca, creates a pipeline for the development of highly qualified scientists who will be on the forefront of creating ... [read post]
